The history of treatment for disordered gaming is brief by comparison with gambling disorder, and its evidence base thinner. For most of gaming’s clinical history — all of the period prior to ICD-11 recognition in 2019 — treatment occurred without formal diagnostic status and without standardized outcome measures. Clinicians working in this space adapted frameworks from substance use and gambling disorder without a specific empirical foundation for doing so.
Cognitive-behavioral therapy represents the best-supported psychological intervention for Gaming Disorder. CBT for Gaming Disorder targets the cognitive distortions that sustain gaming despite consequences — including beliefs about gaming as the primary domain of self-efficacy, competence, and social belonging; catastrophizing about real-world alternatives; and minimization of gaming’s functional impact. Standard CBT components include psychoeducation about reinforcement mechanisms and gaming design; cognitive restructuring targeting maladaptive gaming-specific beliefs; activity scheduling to develop non-gaming sources of reward and mastery; and relapse prevention planning.
The published evidence base, while promising, is limited. A 2017 meta-analysis (Zajac et al.) identified seven controlled treatment studies, all with significant methodological limitations. Effect sizes for gaming frequency and disorder severity were moderate to large, but the methodological limitations preclude strong efficacy conclusions. The fundamental challenge of defining a treatment goal — abstinence is generally not feasible or desirable; controlled use criteria lack standardization — complicates both clinical practice and outcome measurement.
Motivational interviewing occupies an especially important position because the population presents with distinctive engagement challenges. Adolescents and young adults with Gaming Disorder frequently present under parental pressure rather than through self-referral, often do not conceptualize their gaming as problematic, and may have identified gaming as the primary context for their social relationships, sense of competence, and emotional regulation. Pre-contemplative presentation is the rule rather than the exception in clinical samples.
The concept of ‘gaming identity’ — in which gaming is not merely an activity but a central component of the patient’s self-concept — complicates MI in ways that have no clear parallel in other addictions. The clinician must navigate between validating genuine gaming-related skills, relationships, and values while building motivation for change.
Gaming Disorder’s demographic concentration in adolescents and young adults makes family-based intervention particularly important. Family members frequently oscillate between accommodation and confrontation. Structured family-based treatment approaches address these patterns directly by working with the family system rather than the individual patient in isolation.
No medication has regulatory approval for Gaming Disorder in any jurisdiction. ADHD comorbidity warrants particular clinical attention: rates of ADHD in Gaming Disorder clinical samples are substantially elevated above population base rates, and adequate ADHD treatment may produce secondary improvements in gaming disorder severity in ADHD-comorbid presentations.
The treatment goal question — abstinence versus controlled use — has no clean analogue in other addiction categories. Gaming is embedded in educational, social, and occupational contexts in ways that make abstinence impractical for most patients. Clinicians should develop individualized treatment goals addressing: gaming platform-specific risk (MMORPGs vs. single-player games), functional domains most impaired, and patient-defined values around gaming.
Comorbidity in Gaming Disorder clinical samples is the rule rather than the exception. Depression, social anxiety disorder, ADHD, and autism spectrum conditions are the most frequently co-occurring diagnoses. Comprehensive comorbidity assessment is essential; untreated comorbidities are among the most reliable predictors of poor treatment response.